Europe contemplates unified drug prices to counter US pressure to spend more. Experts are guarded in their expectations.
Revolution Medicines’ breakthrough drug for pancreatic cancer was approved more than six months ahead of schedule.
The decision is backed by data from the IMPAACT 2023 clinical study and additional paediatric pharmacokinetic modelling.
Study shows that those with low adherence of blood pressure-lowering drugs had significantly impaired therapeutic effect.
The designation covers CMT as a whole and is not restricted to specific subtypes.
PHP and ARCH have founded Sentivera, a biotech that now has an immunology licensing deal with China-based Haisco.
